US FDA approves J&J's oral psoriasis pill - Reuters
US FDA approves J&J's oral psoriasis pill Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQbGRxR1liVUpqNVc2NEJGUVBmRGFLOWR1TmI1X3dIOWhOQzVnVk1MYzVtLUFCZ0tMZE1CWWQ3dXhlSURGMmJ3TlVuWXZaWk4wZGg1X1B1X2ZNNnBSMm04V3UtTTlTcW1NY0lpUXRHTWZ4d1A5ZDJWMy1xeE1ieEJtMXc4dmRYY2J4YVNjZUVKcm1zUWFqNFU5TTNtVVlENWlMOEZ5OEtjS3lIMTNsd0RtRw?oc=5" target="_blank">US FDA approves J&J's oral psoriasis pill</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
China approves J&J psoriasis pill Icotyde, says drugmaker - Reuters
China approves J&J psoriasis pill Icotyde, says drugmaker Reuters
August 27, 2026 at 05:02 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMUS FDA approves Takeda, Protagonist's drug for rare blood cancer - Reuters
US FDA approves Takeda, Protagonist's drug for rare blood cancer Reuters
August 28, 2026 at 10:16 PMGSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PM